These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
387 related articles for article (PubMed ID: 28720537)
1. Inhaled powder formulation of naked siRNA using spray drying technology with l-leucine as dispersion enhancer. Chow MYT; Qiu Y; Lo FFK; Lin HHS; Chan HK; Kwok PCL; Lam JKW Int J Pharm; 2017 Sep; 530(1-2):40-52. PubMed ID: 28720537 [TBL] [Abstract][Full Text] [Related]
2. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders. Li L; Sun S; Parumasivam T; Denman JA; Gengenbach T; Tang P; Mao S; Chan HK Eur J Pharm Biopharm; 2016 May; 102():132-41. PubMed ID: 26970252 [TBL] [Abstract][Full Text] [Related]
3. High siRNA loading powder for inhalation prepared by co-spray drying with human serum albumin. Chow MYT; Qiu Y; Liao Q; Kwok PCL; Chow SF; Chan HK; Lam JKW Int J Pharm; 2019 Dec; 572():118818. PubMed ID: 31678379 [TBL] [Abstract][Full Text] [Related]
4. Investigation of L-leucine in reducing the moisture-induced deterioration of spray-dried salbutamol sulfate power for inhalation. Li L; Leung SSY; Gengenbach T; Yu J; Gao GF; Tang P; Zhou QT; Chan HK Int J Pharm; 2017 Sep; 530(1-2):30-39. PubMed ID: 28709940 [TBL] [Abstract][Full Text] [Related]
5. Protection of hydrophobic amino acids against moisture-induced deterioration in the aerosolization performance of highly hygroscopic spray-dried powders. Yu J; Chan HK; Gengenbach T; Denman JA Eur J Pharm Biopharm; 2017 Oct; 119():224-234. PubMed ID: 28655664 [TBL] [Abstract][Full Text] [Related]
6. Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers. Li X; Vogt FG; Hayes D; Mansour HM J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):81-93. PubMed ID: 24502451 [TBL] [Abstract][Full Text] [Related]
7. Nano spray-dried pyrazinamide-L-leucine dry powders, physical properties and feasibility used as dry powder aerosols. Kaewjan K; Srichana T Pharm Dev Technol; 2016; 21(1):68-75. PubMed ID: 25331092 [TBL] [Abstract][Full Text] [Related]
8. Using two-fluid nozzle for spray freeze drying to produce porous powder formulation of naked siRNA for inhalation. Liang W; Chow MYT; Chow SF; Chan HK; Kwok PCL; Lam JKW Int J Pharm; 2018 Dec; 552(1-2):67-75. PubMed ID: 30244146 [TBL] [Abstract][Full Text] [Related]
9. Phospholipid-based pyrazinamide spray-dried inhalable powders for treating tuberculosis. Eedara BB; Tucker IG; Das SC Int J Pharm; 2016 Jun; 506(1-2):174-83. PubMed ID: 27091294 [TBL] [Abstract][Full Text] [Related]
10. Leucine improves the aerosol performance of dry powder inhaler formulations of siRNA-loaded nanoparticles. Xu Y; Harinck L; Lokras AG; Gerde P; Selg E; Sjöberg CO; Franzyk H; Thakur A; Foged C Int J Pharm; 2022 Jun; 621():121758. PubMed ID: 35483619 [TBL] [Abstract][Full Text] [Related]
11. Influence of excipients on physical and aerosolization stability of spray dried high-dose powder formulations for inhalation. Shetty N; Park H; Zemlyanov D; Mangal S; Bhujbal S; Zhou QT Int J Pharm; 2018 Jun; 544(1):222-234. PubMed ID: 29678544 [TBL] [Abstract][Full Text] [Related]
12. Dry powder inhalers of gentamicin and leucine: formulation parameters, aerosol performance and in vitro toxicity on CuFi1 cells. Aquino RP; Prota L; Auriemma G; Santoro A; Mencherini T; Colombo G; Russo P Int J Pharm; 2012 Apr; 426(1-2):100-107. PubMed ID: 22301426 [TBL] [Abstract][Full Text] [Related]
13. Spray freeze drying of small nucleic acids as inhaled powder for pulmonary delivery. Liang W; Chan AYL; Chow MYT; Lo FFK; Qiu Y; Kwok PCL; Lam JKW Asian J Pharm Sci; 2018 Mar; 13(2):163-172. PubMed ID: 32104389 [TBL] [Abstract][Full Text] [Related]
14. Dry powder formulation of kanamycin with enhanced aerosolization efficiency for drug-resistant tuberculosis. Momin MAM; Sinha S; Tucker IG; Doyle C; Das SC Int J Pharm; 2017 Aug; 528(1-2):107-117. PubMed ID: 28583333 [TBL] [Abstract][Full Text] [Related]
15. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols. Park CW; Li X; Vogt FG; Hayes D; Zwischenberger JB; Park ES; Mansour HM Int J Pharm; 2013 Oct; 455(1-2):374-92. PubMed ID: 23820131 [TBL] [Abstract][Full Text] [Related]
16. Budesonide dry powder for inhalation: effects of leucine and mannitol on the efficiency of delivery. Rattanupatam T; Srichana T Drug Deliv; 2014 Sep; 21(6):397-405. PubMed ID: 24401124 [TBL] [Abstract][Full Text] [Related]
17. Development of spray-freeze-dried siRNA/PEI powder for inhalation with high aerosol performance and strong pulmonary gene silencing activity. Okuda T; Morishita M; Mizutani K; Shibayama A; Okazaki M; Okamoto H J Control Release; 2018 Jun; 279():99-113. PubMed ID: 29627404 [TBL] [Abstract][Full Text] [Related]
18. Synergistic antibacterial effect of inhaled aztreonam and tobramycin fixed dose combination to combat multidrug-resistant Gram-negative bacteria. Wang J; Kutter JP; Mu H; Moodley A; Yang M Int J Pharm; 2020 Nov; 590():119877. PubMed ID: 32927003 [TBL] [Abstract][Full Text] [Related]
19. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers. Li X; Vogt FG; Hayes D; Mansour HM J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732 [TBL] [Abstract][Full Text] [Related]
20. Dry powder inhaler formulation of high-payload antibiotic nanoparticle complex intended for bronchiectasis therapy: Spray drying versus spray freeze drying preparation. Yu H; Teo J; Chew JW; Hadinoto K Int J Pharm; 2016 Feb; 499(1-2):38-46. PubMed ID: 26757148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]